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SUMMARY.-The sensitivity oflymphocytes to chlorambucil has been assessed
by a simple in-vitro test which has been applied to the cells of normal controls
and of patients with chronic lymphocytic leukaemia. The degree of sensitivity
varied amongst the normal controls and in-vitro resistance of the lymphocytes
in the patients was sometimes found in the absence of in-vivo experience of the
drug. Resistance in-vitro tended to be associated with veryhigh total peripheral
bloodlymphocytecountsbutnotwiththeageofthepatient. Wheretheinforma-
tion was available the in-vitro sensitivity test agreed with the results of bio
-
chemical estimations of drug resistance and with the clinical responses to the
drug. It is suggested that this test may have applications in patient
management.
1N, a study of the karyotypes ofcirculating lymphocytes from cases of chronic
lymphocytic leukaemia it was found that a minor population of cells in patients
treated with chemotherapy had an increased number of chromosomal rearrange-
ments, as compared with normal controls and untreated patients (Lawler et al.,
1968). The question arose whether the rearranged cells in the treated patients
should be attributed to the action of the drugs or to a fundamental disorder of a
minor population of cells in those patients who required treatment. The drugs
used were alkylating agents, such as chlorambucil, sometimes combined with
prednisoloi-ie. The patients studied had not been irradiated.
Alkylating agents are known to react with deoxyribonucleic acid and therefore
rearrangements of the chromosomes are a theoretical possibility. Nevertheless
it must be appreciated that whei-i thesedrugs are successful in controlling the total
leucocvte count in patients with chronic lymphocytic leukaemia most of the cells
that are eliminated are undoubtedly in interphase and thev probably die without
going into a subsequent division cycle.
In-vitro experiments were designed to compare the effect of chlorambucil on
lymphocytes stimulated with mitogenic agents from both normal controls and
patients witli chronic lymphocytic leukaemia. Wheii examining the control
experiments which contained no mitogenic agent, it became apparent that tl'le
simple procedure ofrecording cell survival in lymphocyte populations exposed to
chlorambucil for several davs could be used as a measure of their sensitivitv to
the drug.
MATERIALS AND METHODS
The experiments were set up with the peripheral blood lymphocytes obtained
from 12 patients (9 males and 3 females) with cl-ironic lymphocytic leukaemia494 S. D. LAWLER, K. P. LELE AND C. R. PENTYCROSS
(CLL) and four normal control subjects (2 males and 2 females). From each
individual 20 to 30 ml. of blood were collected into phenol-free heparin (12-5
units/ml.)andsedimenteduprightat37'C.forl-Ilhours. Inmostofthepatients 2 2
almost allthe cells inthesupernatantplasma werelymphocytes, but in onepatient
and in all the controls contamination with other types of white cell necessitated
their removal. This was done by adding medium TC 199 to the supernatant
plasma in the proportion of I : I and incubating at 37' C. for 30 'Minutes in a
medicine bottle. Most ofthegranulocytes andmonocytes became attached to the
flat surface of the bottle, the lymphocytes remaining in suspension. Before
setting up the cultures the lymphocytes were always washed in TC 199 with
heparin (10 units/ml.). The culture medium consisted of TC 199 and human AB
serum in the proportions of 4 : 1. The final lymphocyte concentration was
approximately 1000/MM3.
Preparation and standardization of the dO8e ofchlorambucil
Fifty mg. of chlorambucil (Burroughs Wellcome & Co.) were dissolved in
1 ml. of
" acid-alcohol
" and 9 ml. ofpropylene glycol. From this stock solution
several serial dilutions were made with the culture medium. In the pilot experi-
ments the effect of different doses of the drug were studied on the lymphocytes
from the normal individuals and 0-5/tg./ml. was found to be the suitable dose for
assessing relative sensitivities oflymphocytes to the clrug.
Unstimulateti cultures
Lymphocytes from some patients were exposed to 0-7#g./ml. and 1-0/tg./ml. of drug in addition to the standard dose of 0-5gg./ml. Drug diluent, without
drug, was added to some cultures to ensure that the diluent was innocuous. The
cells were incubated at 37' C. for 120 hours. Every 24 hours 0-5 ml. of cell
suspension from each culture was centrifuged and smears were made from the
cell pellet, air-clried, fixed in methyl alcohol for 10 minutes, and stained with
May-Griinwald and Giemsa.
Stimulated cultures
Afitogens were added to cell cultures from some patients. In the case of both
phytohaemagglutinin (PHA) andpokeweed (PWM) the amount ofmitogen added
was 0-1 ml. reconstituted material per 10 ml. culture. For each experiment with
mitogens, six cultures were set up thus:
1. Cells with PHA (Burroughs Wellcome & Co.).
2. Cells with PWM (Grand Island Biological Co.).
3. Cells with PHA added 10 minutes after chlorambucil.
4. Cells with PWM added 10 minutes after chlorambucil.
5. Cells with PHA, ab initio, drug added at 72 hours.
6. Cells with PWM, ab initio, drug added at 72 hours.
All six cultures were incubated at 37' C. for a total of 118 hours and sampled at 24, 48. 72, 96 and 118 hours. In cultures numbers 3 and 4 chlorambucil was
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FIG. I.-Lymphocytes from a patient (Case 5, 2nd test) with chronic lymphocytic leukae
i
, showing marked sensitivity to three doses ofchlorambucil in vitro in a 120 hour culture.
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FIG. 2.-Lymphocytes from a patient (Case 10) with chronic lymphocytic leukaemis, showing ed resistance to three doses ofchlorambucil in vitro in a 120 hour culture.496 S. D. LAWLER, K. P. LELE AND C. R. PENT'YCROSS
Sen,gitivity 8coreq
Cells were scored as
" dead
" ifthey were pyknotic. Smudge cells were like-
wise scored as
" dead ". For the purposes of these experiments cells not falling
into either ofthe above categories were regarded as
" surviving ".
A score of sensitivity was obtained by the difference between the percentage
of cells surviving in control cultures and in those containing chlorambucil.
Sensitive (S) 30+
Moderately sensitive (MS) 15-29
Resistant (R) 0-14
RESULTS
Fig. I and 2 showgraphs ofthe cell survival patterns oflymphocytes from two
patients measured by daily sampling over a period of 120 hours at three different
concentrations of chlorambucil.
In Fig. I a markeddegree ofsensitivity is evident in the culture treated with a
concentration of 0-5,ag./ml. of chlorambucil. The higher concentrations are
associated with even higher scores of sensitivity (Case 5, 2nd test, Table 11).
The drug diluent is seen to be innocuous.
Fig. 2 shows a typical graph of survival oflymphocytes that are resistant to
chlorambucil (Case 10, Table 11).
Table I shows the results ofthe sensitivity tests on four normal subjects. The
subjectsarearrangedaccordingtothesensitivityoftheirlymphocytesto0-5/tg./ml.
ofdrug at 120 hours. It will be observed that the lymphocytes from two females
and one male were classified as sensitive whereas those from the remaining male
were only moderately sensitive.
TABLE I.-Sengitivity Teqt8 on the Lymphocyte,8 of Normal Contro18
120 hours
Concentration Sensitivity*
LNO. Age Sex of the drug score
I 26 F 0 5 pg./ml. 8 (54)
24 F 0 5 pg./ml. S (47)
3 28 M 0 5 pg./ml. 8 (30)
4 26 M 0 5 pg./ml. M.S (18)
Sensitivity score given by % lymphocytes surviving in control culturesminits % lymphocytes surviving in cultures treated with chlorambucil.
8 = Sensitive 30+. AIS =: Aloderately Sensitive 15-29. R == Resistant 0-14.
Table II shows the complete results on the 12 patients also arranged according
to theirlymphocyte sensitivity to 0-5,ag./ml. ofdrug at 120 hours. The lympho-
cytes from Case No. 1, 2 and 3 were classified as sensitive. Case No. 4 had only moderately sensitive lymphocytes but she had never been treated with chloram-
bucil. Case No. 5 showed variation in sensitivity at different times. In the first
testthelymphocytes were resistant to aconcentrationof0-5 Itg./ml.butmoderately sensitive to the higher concentrations. In the second test the lymphocytes were
sensitive to 0-5,ug./ml: the patient has now responded clinically to the drug. All the other cases were classified as resistant: of these only Case 6 had not
been treated with chlorambucil at any time. When the concentration ofchloram-
bucil in the cultures was increased to 0-7 #g./ml. or 1-0,ag./mI., the sensitivity
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TABLEII.-Se,n8itivity Te8t8 on LymphOCyte8from Patient8 with ChronicLymphocytic Leukaemia
Lymphocytes
per cu.mm.
in peripheral
blood
9800
Conc.
of the
drug
(pg.Iml.)
0.5
Date
of
test Clinical details
M. 6.70 Diagnosed 21 years (plus ca. left
ear). No anti-leukaemic drugs
given.
2.11.70 Diagnosed 22 months. Has had
prednisolone and chlorambucil.
On therapy on the day of the
experiment.
9.11.70 Diagnosed 16 months. Treated
with chlorambucil for 5 months
-no treatment for 2 months
6.4.70 Diagnosed 21 years. Vulvectomy
for Ca. vulva in 1962. No
anti-leukaemic drugs given.
9.11.70 Diagnosed 2 years and 8 months.
Has been treated with
prednisolone and chlorambucil.
No therapy for 6 months.
1.2.71
24.8.70 Diagnosed 2 months. No
treatmentgiven.
28.9.70 Diagnosed 23 years. Has been
treated with chlorambucil. No
treatment for last 11 months.
16.11.70. Diagnosed 9 months. Has had
chlorambucil,prednisolone and
blood transfusions-on no
therapy for last 6 months.
8. 3. 71 . Diagnosed 2 months. Has been
treated with prednisolone and
chlorambucil and had blood
transfusions. Was onpredniso-
lone and chlorambucil at the
time of the experiment.
24.11.70. Diagnosed4lyears. Treatedwith
chlorambucil and steroids for
3i years. No treatment for the
last yeax.
3.8-70 . Diagnosed 9 years. Has been
treated with chlorambucil,
prednisolone and blood
transfusions-was on predniso-
lone at the time of the
experiment.
12.10. 70 Diagnosed 7 years. Has had
chlorambucil, prednisolone,
cyclophosphamide and blood
transfusions. No specific
treatment for the last 4 months.
Splenectomy in 1966.
Sensitivity*
score at
120 hours
S (82)
Case
No.
(1) AJW
Age Sex
69 . M
(2) KE . 56 . F 870 0- 5 S (48)
0- 7 S (53)
(3) JBH . 69 . Al . 34000
(4) DG . 82 . F 64600
(5) GS . 66 . M . 26878
75716
0- 5 8 (31)
0- 7 S (40)
1.0 S (46)
0.5 . M.S (19)
1- 0 . M.S (18)
0-5 R (2)
0- 7 . M.S (23)
1-0 . M.S (24)
0- 5 S (32)
0- 7 S (49)
1.0 S (64)
0-5 R (10)
0-5 R (8)
(6) KR
(7) IF
. 69 . F 305550
. 70 . M 7524
9350
364050
116840
212000
53000
(8) RER . 72 . M
(9) AA . 57 . M
(10) GN . 48 . M
(11) RP . 53 . M
(12) WLC . 70 . M
0.5
0- 7
1.0
0.5
0- 7
1.0
. R (7)
R (1)
R (14)
R (4)
R (6)
R (14)
0
- 5 - R (2)
0- 7 R (7)
1-0 R (11)
0-5 R (0)
0- 5 R (0)
0- 7 R (0)
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FIG. 3.-Lymphocytes from a patient (Case 6) with chronic lymphocytic leuka-ernia, showing marked resistance to 0-5 pg./ml. of chlorambucil in the presence ofmitogens.
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FIG. 4.-Lymphocytes from apatient (Case 1) with chronic lymphocytic leukaernia, showing a difference in sensitivity according to the time at which drug and mitogens were added.SENSITIVITY OF LYMPHOCYTES TO CHLORAMBUCIL 499
Fig. 3 and 4 illustrate the effects of the addition ofmitogens on the action of
the drug onlymphocyte cultures which were sampleddaily up to 118 hours.
Fig. 3 demonstrates that the addition of mitogens to resistant lymphocytes
does not alter theirsensitivity (Case No. 6, Table11).
Fig. 4 shows the effect of the addition of mitogens to lymphocytes that are
sensitive to chlorambucil in-vitro. Ifthe drug is present ab initio, the addition of
mitogen 10 minutes afterwards does not alterthesensitivitypattern ofthelympho-
cytes. On the otherhand, ifthe drug is added three days after the mitogen, then
at 5 days the lymphocytes are apparently resistant to chlorambucil. However it
must be appreciated that the cells have only been exposed to clrug for 2 days (Case No. 1, Table 11).
DISCUSSION
Whilstassessingdrug-induced chromosomaldamage in vitro, it became appar-
ent that the sensitivity to chlorambucil of the lymphocytes of normal controls
and patients with chronic lymphocytic leukaemia could be estimated by a simple in-vitro test. In this test lymphocytes that had not been exposed to mitogens
were treated with chlorambucil, the standard dose being 0-5 ltg. per ml. of culture
medium. Thelymphocytes were incubated at 37' C. and the number ofsurviving cells was counted insamples takendaily over aperiod of5days.
The most clear-cut differences between sensitive and resistant Po-pulations of
lymphocytes were obtained after 5 days' incubation. The test cannot be used
with lymphocytes that are sensitive to the manipulations preceding incubation
because theygive a low score ofsurviving cells in the absence ofthe drug.
In ourexperience a morereliableresultisgivenbyreadingthetestsfromstained
smears than by the use of the trypan blue dye exclusion test of ceu viability. Degenerating cells are "lost"from wetpreparations butthey show up in smears as
smudges in which chromatin is identifiable. The stained smears also have the
advantage ofproviding a permanent record ofthe test.
The sensitivity of lymphocytes to chlorambucil varies in normal controls.
Using our criteria for scoring, the lymphocytes of one ofthe normal controls were
onlymoderately sensitive to the standard dose ofthedrug: a score in the sensitive
range was obtained by increasing the concentration of chlorambucil to I ag. per ml. of culture. Two patients had not been treated with chlorambucil, one (Case
4), had lymphocytes which were only moderately sensitive to the drug, the other
(Case 6), had cellsthat were resistant. Thusresistance oflymphocytes to chloram-
bucil in the in-vitro test amongstpatients with chroniclymphocytic leukaemia can
be present in the absence ofin vivoexperience ofthedrug. This is in accord with
the observation of
" natural
" resistance of the disease process to chlorambucil
therapy (Larionov, 1962).
The other patients with resistant lymphocytes (Cases 7, 8, 9, 10, 11 and 12) had all been treated with chlorambucil at some time during the course of their
disease. The lymphocytes of these patients were still resistant when exposed to
concentrations of drugup to I Itg. per ml. ofculture. Most ofthepatients whose
lymphocytes showed resistance had very high total lymphocyte counts, whilst
patients whose lymphocytes were sensitive included those with both high and
low total counts. Drug resistance was notnecessarily a feature of old age. The experiments in which the lymphocytes were exposed to -both mitogenic
agents and chlorambucil showed that the classification of the cells as resistant or500 S. D. LAWLER, K. P. LELE AND C. R. PENTYCROSS
sensitiveremainedthe same. Perhaps this is notsurprising in view ofthe factthat
only aminority ofthe cellpopulationresponds to mitogenic stimulation in chronic
lymphocytic leukaemia. Thereis, however, asuggestion in the datathatmitogens
may exert aprotective effect. Forexample, the cells ofCaseNo. 1, (Fig. 4) showed
ahighersurvivalrate ifthey wereexposedtomitogensfor 3daysbeforetheaddition
ofthe drug, as compared with t'ile cultures in which drug was added first followed
by mitogen. This result can be questioned because all the experiments were
terminated at 5 days. It is a tenable argument that in order to make a valid
comparison the experiment in which the drug was added 3 days after the mitogen
should not have been terminated until 7 days.
Drs. K. Harrap and Bridget Hill, working at the Chester Beatty Research
Institute areinvestigating theproblem ofdrug resistance toalkylating agents by a
biochemical method. They have measured the capacity of the lymphocytes to
degrade chlorambucil in four cases that we have also studied (Hill, 1968; Harrap
andHill,personalcommunication,1971). Case4wasfoundbyustohavelympho-
cytes that were only moderately sensitive to chlorambucil, and in the biochemical
testthe cells werefound to be sensitive butwith
" someslightdegradativeability ".
Case II was scored as sensitive biochemically in 1968, but had become resistant
by 1969, the lymphocytes were resistant in our test in 1970. Case 9 showed
resistance in both the biochemical and the in-vitro culture tests, both tests being
done within I month of each other. The behaviour ofthe lymphocytes of Case 5
is particularly interesting since the cells have been found to be either sensitive or
resistant at different times by both methods. Thus the results obtained by the
two methods are in agreement.
The assessment of the accord between the in-vitro culture test of sensitivity
and the response of the patients to chlorambucil is complicated by the fact that
some of the patients have not been treated with the drug, whilst others have had
other forms of therapy concomitantly. Where it has been possible to make a
clinical judgement as to whether the patient was responding to chlorambucil at a
par-ticular time, there is agreement with the results of the in-vitro test (GaltoD,
personal communication, 1971).
Chlorambucil undoubtedly can kill cells in interphase, and in this respect
differsfrom othercytotoxicdrugs. Thesimple in-vitro testthat we havehappened
upon exploits this activity. We hope that the test may have applications in
patient management.
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